WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹643 Cr | ₹882 Cr | ₹866 Cr | ₹840 Cr | ₹639 Cr |
What is the latest Contingent Liabilities ratio of WOCKHARDT ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹882 Cr |
| Mar2023 | ₹866 Cr |
| Mar2022 | ₹840 Cr |
| Mar2021 | ₹639 Cr |
How is Contingent Liabilities of WOCKHARDT Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -27.11 | |
| Mar2024 | ₹882 Cr | 1.87 | |
| Mar2023 | ₹866 Cr | 3.13 | |
| Mar2022 | ₹840 Cr | 31.46 | |
| Mar2021 | ₹639 Cr | - | |
Compare Contingent Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,294.2 Cr | 0.7% | -3.7% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 0.7% |
-3.7% |
-5% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses